ABEONA THERAPEUTICS INC. Debt Securities, Available-for-sale
ABEONA THERAPEUTICS INC. (ABEO) had Debt Securities, Available-for-sale of $90.60 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2026-08-13
- 2026-06-30: Debt Securities, Available-for-sale $90.60M.
- 2026-03-31: Debt Securities, Available-for-sale $106.90M.
- 2025-12-31: Debt Securities, Available-for-sale $112.97M.
- 2025-09-30: Debt Securities, Available-for-sale $124.23M.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2026-06-30 | $90.60M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $106.90M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $112.97M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $124.23M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $61.98M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $68.22M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $74.36M 10-K · filed 2026-03-17 |
| 2024-09-30 | $93.97M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $88.28M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $44.79M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $37.75M 10-K · filed 2025-03-20 |
| 2023-09-30 | $49.04M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $30.55M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $35.68M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $37.93M 10-K · filed 2024-03-18 |
| 2022-09-30 | $12.43M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $13.96M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $10.99M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $12.09M 10-K · filed 2023-03-29 |
| 2021-09-30 | $23.22M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $50.38M 10-Q · filed 2021-07-28 |
| 2021-03-31 | $72.51M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $82.44M 10-K · filed 2022-03-31 |
| 2020-09-30 | $88.45M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $93.34M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $75.89M 10-Q · filed 2020-05-06 |
| 2019-06-30 | $19.90M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $42.39M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $66.22M 10-K · filed 2020-03-16 |
| 2018-09-30 | $78.63M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $69.85M 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |